Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to JAK inhibitors versus adalimumab: a nationwide cohort study: comment on the article by Hoisnard et al.
Arthritis & Rheumatology
論文與作者
Arthritis Rheumatol. 2025;77(8):1113-1114.
Jing-Jin Hu; Yang-Yang Lu; Jun-Kang Zhao; Dan Ma; Li-Yun Zhang; James Cheng-Chung Wei